HALO - Halozyme Therapeutics, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts10101110
Avg. Estimate-0.22-0.21-0.82-0.55
Low Estimate-0.25-0.26-1.07-0.89
High Estimate-0.13-0.12-0.5-0.26
Year Ago EPS-0.26-0.230.45-0.82
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts8899
Avg. Estimate32.03M32.97M137.75M190.41M
Low Estimate28M29M121M140.08M
High Estimate42.4M44.4M196M306M
Year Ago Sales29.57M33.75M316.61M137.75M
Sales Growth (year/est)8.30%-2.30%-56.50%38.20%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-0.25-0.24-0.10.72
EPS Actual-0.26-0.230.020.85
Difference-0.010.010.120.13
Surprise %-4.00%4.20%120.00%18.10%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.22-0.21-0.82-0.55
7 Days Ago-0.2-0.19-0.77-0.51
30 Days Ago-0.18-0.18-0.72-0.48
60 Days Ago-0.17-0.17-0.62-0.4
90 Days Ago-0.17-0.17-0.64-0.41
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 Days1122
Up Last 30 Days1122
Down Last 30 Days5462
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesHALOIndustrySectorS&P 500
Current Qtr.15.40%N/AN/A0.34
Next Qtr.8.70%N/AN/A0.40
Current Year-282.20%N/AN/A0.17
Next Year32.90%N/AN/A0.11
Next 5 Years (per annum)55.00%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A